Trove of genetic data to spur cancer research released

Updated on: August 10,2025 0

Trove of genetic data to spur cancer research released

Updated on:August 10,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on: October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on:October 04,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on: October 03,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on:October 03,2025 0

An aggressive childhood cancer case opens new avenues for advanced cell therapies

Updated on: August 10,2025 0

An aggressive childhood cancer case opens new avenues for advanced cell therapies

Updated on:August 10,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025 0

Researchers uncover potential mechanism driving treatment resistance in common breast cancer

Updated on: September 08,2025 0

Researchers uncover potential mechanism driving treatment resistance in common breast cancer

Updated on:September 08,2025 0

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Updated on: September 30,2025 0

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Updated on:September 30,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on: October 02,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on:October 02,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0

Slowdown in progress found with cancer survival in England and Wales

Updated on: September 05,2025 0

Slowdown in progress found with cancer survival in England and Wales

Updated on:September 05,2025 0